Myelophthisic anemia
Myelophthisic Anemia
Myelophthisic anemia (pronunciation: my·elo·phthis·ic anemia, /ˌmaɪələfˈθɪsɪk əˈniːmiə/) is a type of anemia that occurs when the bone marrow is replaced by nonhematopoietic or abnormal cells. This replacement leads to the destruction or loss of blood-forming cells, causing anemia.
Etymology
The term "myelophthisic" is derived from the Greek words "myelos" meaning marrow and "phthsis" meaning wasting. It refers to the wasting or displacement of the bone marrow.
Causes
Myelophthisic anemia is usually caused by conditions that lead to the replacement of the bone marrow. These conditions can include cancer, fibrosis, granulomatous disease, and other diseases that affect the bone marrow.
Symptoms
Symptoms of myelophthisic anemia can include fatigue, weakness, shortness of breath, and pale skin. In severe cases, it can lead to heart failure due to the increased workload on the heart.
Diagnosis
Diagnosis of myelophthisic anemia is typically made through a blood test and a bone marrow biopsy. The blood test can show anemia and the presence of immature or abnormal cells. The bone marrow biopsy can confirm the replacement of the bone marrow.
Treatment
Treatment of myelophthisic anemia focuses on treating the underlying cause of the bone marrow replacement. This can include chemotherapy, radiation therapy, or bone marrow transplant.
Related Terms
- Anemia
- Bone Marrow
- Cancer
- Fibrosis
- Granulomatous Disease
- Heart Failure
- Chemotherapy
- Radiation Therapy
- Bone Marrow Transplant
External links
- Medical encyclopedia article on Myelophthisic anemia
- Wikipedia's article - Myelophthisic anemia
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski